# Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer’s disease

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/meaningful-benefits-a-framework-to-assess-disease-modifying-therapies-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Sheila Seleri Assunção,Reisa A. Sperling,Craig Ritchie,Diana Kerwin,Paul Aisen,Claire J. Lansdall,Alireza Atri,Jeffrey L. Cummings |
| Citations | 72 |
| DOI | 10.1186/s13195-022-00984-y |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://alzres.biomedcentral.com/track/pdf/10.1186/s13195-022-00984-y |
| OpenAlex ID | https://openalex.org/W4224216819 |
| PMID | 35440022 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Claire J. Lansdall](https://scholariq.org/researchers/claire-j-lansdall/)

## Paper primary topic

- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)

## Paper topics

- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)
- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)
- [Amyotrophic Lateral Sclerosis Research](https://scholariq.org/topics/amyotrophic-lateral-sclerosis-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.